ACC: Antithrombotic Benefit Found Lacking in Low-Risk A-Fib
Researchers found low-risk patients fared better without any antithrombotic therapy
ACC: Meds Targeting PCSK9 Show Benefit for High-Risk Patients
Evolocumab and inclisiran inhibit proprotein convertase subtilisin-kexin type 9
Appeals Court Upholds Restaurant Salt Warning
Court upholds rule requiring warning about menu items exceeding daily recommended sodium limit
High-Intensity Aerobic Exercise May Help Reverse Cellular Aging
More robust increase in gene transcripts for high-intensity interval training versus other modalities
Wearable Radiation Safety Devices Offer Some Protection
Leaded glasses reduce dose to ocular lens by 27 to 62 percent; surgical cap reduces dose by 3.3 percent
Noninvasive Imaging Deemed Adequate in Prediction of MACE
CT angio + perfusion imaging similar to ICA, photon emission CT for two-year MACE prediction
Women Underrepresented Among Grand Rounds Speakers
Women presented a median of 28.3 percent of the total sessions
Adverse CV Events Up Post Failure of Fertility Therapy
Failed fertility therapy linked to 19 percent increased risk of cardiovascular events later in life
Support for Health Law Up to 48 Percent in February
Kaiser Family Foundation poll: two-thirds of Americans feel Medicaid should continue as is today
Many A-Fib Patients Not Getting Appropriate Anticoagulation Rx
More than 80 percent of ischemic stroke patients weren't getting adequate anticoagulation
